Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEVP, Research & InvestmentsCIK 0001838139
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 2 | Urist MarshallEVP, Research & Investments |  RPRXRoyalty Pharma plcGrant or award | A | — 5,341 sh | Nov 6, 2026 traded Nov 4, 2026 | |
Urist MarshallEVP, Research & Investments |
| RPRXRoyalty Pharma plc Derivative conversion |
| C |
| — 150.0K sh |
| Nov 6, 2026 traded Nov 6, 2026 |
| 6 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Derivative conversion | C | — 15.0K sh | Nov 6, 2026 traded Nov 6, 2026 |
| 18 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $239K 4,126 sh | Sep 30, 2026 traded Sep 28, 2026 |
| 5 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Gift | G | — 3,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 2 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Grant or award | A | — 8,252 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 17 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $502K 9,098 sh | Jun 25, 2026 traded Jun 24, 2026 |
| 14 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Grant or award | A | — 20.0K sh | Feb 13, 2026 traded Feb 11, 2026 |
| 21 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $805K 20.0K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 20 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $790K 20.0K sh | Jan 20, 2026 traded Jan 16, 2026 |
| 20 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $816K 20.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 16 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $786K 20.0K sh | Dec 29, 2025 traded Dec 26, 2025 |
| 16 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $768K 20.0K sh | Dec 22, 2025 traded Dec 19, 2025 |
| 33 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $714K 18.2K sh | Dec 9, 2025 traded Dec 5, 2025 |
| 25 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $914K 23.3K sh | Dec 9, 2025 traded Dec 5, 2025 |
| 13 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Grant or award | A | — 4,626 sh | Nov 7, 2025 traded Nov 5, 2025 |
| 21 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Derivative conversion | C | — 160.0K sh | Nov 7, 2025 traded Nov 7, 2025 |
| 13 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Derivative conversion | C | — 16.0K sh | Nov 7, 2025 traded Nov 7, 2025 |